KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Brad H. Rovin, Isabelle Ayoub, Tak Mao Chan, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Jürgen Floege
Abstract
This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources.
Topics & Concepts
GuidelineLupus nephritisMedicineIntensive care medicineGrading (engineering)Randomized controlled trialClinical PracticeClinical trialEvidence-based medicineMEDLINECritical appraisalAlternative medicinePhysical therapyDiseasePathologyPolitical scienceCivil engineeringEngineeringLawSystemic Lupus Erythematosus ResearchRenal Diseases and GlomerulopathiesLipid metabolism and disorders